Friday, July 10, 2026

pharma · Kidney Dysfunction · Obesity

LianBio

LianBio clinical programs — 28 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
2019 Founded
47 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
2019
Employees
47
Programs
28
Drugs
40
Patents
0
Intelligence · Clinical Programs

LianBio projects

28 ClinicalTrials.gov programs sponsored by LianBio.

LianBio has 28 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. HS-20094 Injection

    Jian Li

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial
  2. Irinotecan liposome、5-Fluorouracil、Leucovorin

    Jian Li

    Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy

    phase 3 small molecule completed

    1 trial
  3. Placebos

    Jian Li

    Advanced Non-small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial
  4. SHR-1210

    Jian Li

    Locally Advanced or Metastatic and Unresectable HCC

    phase 3 small molecule completed

    1 trial
  5. HRS-6213

    Jian Li

    Patients With Solid Tumors

    phase 2 small molecule active

    1 trial
  6. High-Low Dose Radiotherapy

    Jian Li

    Nasopharyngeal Carcinoma (NPC)

    phase 2 other active

    1 trial
  7. Karelizumab combined with etoposide and cisplatin

    Jian Li

    Carcinoma

    phase 2 small molecule active

    1 trial
  8. Part1:Recombinant two-component COVID-19 vaccine (CHO cell)

    Jian Li

    COVID-19

    phase 2 mab completed

    1 trial
  9. SHR20004

    Jian Li

    Obesity

    phase 2 small molecule active

    1 trial
  10. 626

    Jian Li

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial
  11. 68Ga-FAPI-04

    Jian Li

    Fibrosis

    phase 1 small molecule active

    1 trial
  12. APL-1202 and APL-1501 (Single ascending dose)

    Jian Li

    Bladder Cancer

    phase 1 small molecule active

    1 trial
  13. Ad5-EBOV

    Jian Li

    Ebola Virus Disease

    phase 1 mab completed

    1 trial
  14. Daridorexant

    Jian Li

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  15. GST-HG121 tablets

    Jian Li

    Pharmacokinetics

    phase 1 small molecule active

    1 trial
  16. HRS-2329 Tablet

    Jian Li

    Advanced Solid Tumors Harboring RAS Mutations or Amplifications

    phase 1 small molecule active

    1 trial
  17. HS-10345 84mg

    Jian Li

    Treatment Resistant Depressive Disorder

    phase 1 small molecule completed

    1 trial
  18. HS-10382(Part 1: Dose escalation)

    Jian Li

    CML, Chronic Phase

    phase 1 small molecule active

    1 trial
  19. Nemonoxacin

    Jian Li

    Kidney Dysfunction

    phase 1 small molecule active

    1 trial
  20. SHR-1501

    Jian Li

    Advanced Malignancies

    phase 1 small molecule completed

    1 trial
  21. SHR1459 tablet

    Jian Li

    B-cell Tumors

    phase 1 small molecule completed

    1 trial
  22. SHR2554 and Itraconazole

    Jian Li

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial
  23. [14C] HRS-9190

    Jian Li

    Healthy Adult Male

    phase 1 small molecule active

    1 trial
  24. Bupivacaine Liposome Injection

    Jian Li

    Local Analgesia Via Infiltration

    approved small molecule active

    1 trial
  25. Basic treatment

    Jian Li

    Major Depressive Disorder

    small molecule completed

    1 trial
  26. Conventional Artificial Cycle Therapy

    Jian Li

    Infertility, Female

    small molecule active

    1 trial
  27. Doxycycline

    Jian Li

    Amyloidosis; Systemic

    small molecule completed

    1 trial
  28. Radiotherapy combined with TKI and Anti-PD-1 Antibody

    Jian Li

    Stage IIIA Hepatocellular Carcinoma

    other active

    1 trial

Frequently asked questions

How many clinical projects does LianBio have?

28 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.